Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 32% ± 11% | |
lung | 16 studies | 35% ± 14% | |
intestine | 12 studies | 31% ± 16% | |
kidney | 8 studies | 33% ± 12% | |
brain | 8 studies | 23% ± 5% | |
liver | 7 studies | 35% ± 20% | |
bone marrow | 5 studies | 27% ± 4% | |
eye | 5 studies | 30% ± 11% | |
uterus | 5 studies | 37% ± 17% | |
lymph node | 5 studies | 36% ± 18% | |
pancreas | 4 studies | 37% ± 15% | |
placenta | 4 studies | 39% ± 20% | |
prostate | 4 studies | 29% ± 10% | |
breast | 4 studies | 32% ± 6% | |
adrenal gland | 3 studies | 30% ± 10% | |
esophagus | 3 studies | 46% ± 27% | |
thymus | 3 studies | 58% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1241.30 | 258 / 258 | 100% | 40.89 | 230 / 230 |
esophagus | 100% | 1450.00 | 1445 / 1445 | 100% | 67.06 | 183 / 183 |
ovary | 100% | 1339.06 | 180 / 180 | 100% | 58.06 | 430 / 430 |
skin | 100% | 1708.89 | 1809 / 1809 | 100% | 40.68 | 472 / 472 |
thymus | 100% | 1194.33 | 653 / 653 | 100% | 44.35 | 605 / 605 |
uterus | 100% | 1407.00 | 170 / 170 | 100% | 82.92 | 459 / 459 |
brain | 100% | 1013.89 | 2639 / 2642 | 100% | 38.45 | 705 / 705 |
intestine | 100% | 1274.37 | 966 / 966 | 100% | 70.55 | 526 / 527 |
bladder | 100% | 1232.62 | 21 / 21 | 100% | 74.91 | 503 / 504 |
stomach | 100% | 990.01 | 358 / 359 | 100% | 65.81 | 286 / 286 |
lung | 100% | 1257.99 | 577 / 578 | 100% | 54.70 | 1151 / 1155 |
prostate | 100% | 1154.48 | 245 / 245 | 99% | 41.45 | 499 / 502 |
breast | 100% | 1380.10 | 459 / 459 | 99% | 55.06 | 1106 / 1118 |
kidney | 100% | 1282.64 | 89 / 89 | 99% | 28.76 | 891 / 901 |
liver | 100% | 1085.29 | 225 / 226 | 99% | 35.71 | 403 / 406 |
pancreas | 98% | 620.61 | 323 / 328 | 99% | 40.32 | 176 / 178 |
adipose | 100% | 1279.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 35.52 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 91.61 | 29 / 29 |
spleen | 100% | 1433.22 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 68.30 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 133.12 | 1 / 1 |
blood vessel | 100% | 1120.80 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 706.06 | 793 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 894.98 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 1337.04 | 792 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000387 | Biological process | spliceosomal snRNP assembly |
GO_0036261 | Biological process | 7-methylguanosine cap hypermethylation |
GO_1903241 | Biological process | U2-type prespliceosome assembly |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0008380 | Biological process | RNA splicing |
GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
GO_0005686 | Cellular component | U2 snRNP |
GO_0005685 | Cellular component | U1 snRNP |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071007 | Cellular component | U2-type catalytic step 2 spliceosome |
GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
GO_0005683 | Cellular component | U7 snRNP |
GO_0034709 | Cellular component | methylosome |
GO_0034719 | Cellular component | SMN-Sm protein complex |
GO_0005829 | Cellular component | cytosol |
GO_0005684 | Cellular component | U2-type spliceosomal complex |
GO_0005682 | Cellular component | U5 snRNP |
GO_0005687 | Cellular component | U4 snRNP |
GO_0034715 | Cellular component | pICln-Sm protein complex |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0030532 | Cellular component | small nuclear ribonucleoprotein complex |
GO_0005689 | Cellular component | U12-type spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SNRPF |
Protein name | Sm protein F Small nuclear ribonucleoprotein F (snRNP-F) (Sm protein F) (Sm-F) (SmF) Small nuclear ribonucleoprotein polypeptide F |
Synonyms | PBSCF |
Description | FUNCTION: Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome . Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes . As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs . As part of the U7 snRNP it is involved in histone 3'-end processing . . |
Accessions | P62306 ENST00000553192.5 F8W0W6 ENST00000552085.1 ENST00000266735.10 A0A0B4J254 |